The Wake Forest Baptist Comprehensive Cancer Center (WFBCCC) Administrative Core includes both Senior Leadership and central Administration, and oversees all strategic, operational, and financial aspects of the WFBCCC. The two teams work in tandem to deliver the goals of the Center, thereby meeting the mission of improving the lives of people in the multi-state Piedmont and southern Appalachian region. The Senior Leadership team establishes the vision for the WFBCCC to address the strategic priorities and operational aspects of the Center, such as Program goals, transdisciplinary and translational research needs and assessment, strategic recruitment, pilot projects, external speakers, and patient accruals to clinical trials. The Deputy Director and the Associate Directors for Basic Sciences, Population Sciences, Clinical Research, Cancer Health Equity, Shared Resources, Informatics, and Administration attend these meetings. All but one of these senior leaders is newly-appointed to these roles, in response to feedback from the External Advisory Board and the 2011 Summary Statement to expand the Senior Leadership ranks in further support of the Director. Under Dr. Pasche's leadership, the WFBCCC is stronger because of this structure, and these leaders have helped create the new initiatives described in this application and brought a fresh perspective to the WFBCCC's strategic vision. The Administrative team facilitates the implementation of the vision set by WFBCCC Senior Leadership and fosters an environment of collaboration and interaction with its membership. It consists of 13 FTEs and oversees all aspects of the Center's operations, including Shared Resource personnel and process management, informatics infrastructure support and expertise, financial leadership and management, faculty recruitment and space utilization, pilot award programs, Planning and Evaluation facilitation (internal and external advisory boards/committees and speakers), clinical research management, membership management and communication, cancer health equity and community outreach activities, and personnel support. The Administrative team is also responsible for all required CCSG reporting related to membership accomplishments (e.g. funding, publications, Shared Resource usage, and clinical trial accruals). The two groups are closely linked through frequent formal and informal meetings, allowing the WFBCCC Administrative team to be responsive to the direction set forth by the Senior Leadership.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA012197-46
Application #
10092977
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-02-01
Project End
2022-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
46
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Dutta, Samrat; Rivetti, Claudio; Gassman, Natalie R et al. (2018) Analysis of single, cisplatin-induced DNA bends by atomic force microscopy and simulations. J Mol Recognit 31:e2731
Paek, M-S; Nightingale, C L; Tooze, J A et al. (2018) Contextual and stress process factors associated with head and neck cancer caregivers' physical and psychological well-being. Eur J Cancer Care (Engl) 27:e12833
Atkins, Hannah M; Appt, Susan E; Taylor, Robert N et al. (2018) Systemic Iron Deficiency in a Nonhuman Primate Model of Endometriosis. Comp Med 68:298-307
Pardee, Timothy S; Anderson, Rebecca G; Pladna, Kristin M et al. (2018) A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia. Clin Cancer Res 24:2060-2073
Yang, M; Forbes, M E; Bitting, R L et al. (2018) Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system? Ann Oncol 29:311-323
Godwin, Ryan C; Gmeiner, William H; Salsbury Jr, Freddie R (2018) All-atom molecular dynamics comparison of disease-associated zinc fingers. J Biomol Struct Dyn 36:2581-2594
Lamar, Zanetta S; Dothard, Andrew; Kennedy, LeAnne et al. (2018) Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study. Leuk Lymphoma 59:1871-1877
Votanopoulos, Konstantinos Ioannis; Bartlett, David; Moran, Brendan et al. (2018) PCI is Not Predictive of Survival After Complete CRS/HIPEC in Peritoneal Dissemination from High-Grade Appendiceal Primaries. Ann Surg Oncol 25:674-678
Bhatt, Nikunj B; Pandya, Darpan N; Dezarn, William A et al. (2018) Practical Guidelines for Cerenkov Luminescence Imaging with Clinically Relevant Isotopes. Methods Mol Biol 1790:197-208
Melvin, Ryan L; Xiao, Jiajie; Berenhaut, Kenneth S et al. (2018) Using correlated motions to determine sufficient sampling times for molecular dynamics. Phys Rev E 98:023307

Showing the most recent 10 out of 548 publications